Bristol-Myers Squibb Company (BMY)
NYSE: BMY · Real-Time Price · USD
58.84
+0.47 (0.81%)
Dec 5, 2024, 4:00 PM EST - Market closed
BMY Stock Forecast
Stock Price Forecast
The 13 analysts with 12-month price forecasts for BMY stock have an average target of 53.92, with a low estimate of 39 and a high estimate of 73. The average target predicts a decrease of -8.36% from the current stock price of 58.84.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for BMY stock from 14 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 2 | 1 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 1 |
Hold | 13 | 11 | 12 | 12 | 13 | 11 |
Sell | 1 | 2 | 2 | 2 | 2 | 2 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 17 | 16 | 17 | 16 | 16 | 14 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Wolfe Research | Wolfe Research | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Nov 15, 2024 |
Citigroup | Citigroup | Hold Maintains $55 → $60 | Hold | Maintains | $55 → $60 | +1.97% | Nov 12, 2024 |
BMO Capital | BMO Capital | Hold Maintains $57 → $61 | Hold | Maintains | $57 → $61 | +3.67% | Nov 12, 2024 |
Leerink Partners | Leerink Partners | Hold → Buy Upgrades $55 → $73 | Hold → Buy | Upgrades | $55 → $73 | +24.07% | Nov 12, 2024 |
Morgan Stanley | Morgan Stanley | Sell Maintains $36 → $39 | Sell | Maintains | $36 → $39 | -33.72% | Nov 12, 2024 |
Financial Forecast
Revenue This Year
47.87B
from 45.01B
Increased by 6.35%
Revenue Next Year
47.24B
from 47.87B
Decreased by -1.31%
EPS This Year
0.92
from 3.86
Decreased by -76.12%
EPS Next Year
7.12
from 0.92
Increased by 672.08%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 50.2B | 51.2B | 48.0B | |||
Avg | 47.9B | 47.2B | 44.6B | |||
Low | 45.1B | 42.6B | 40.7B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 11.6% | 7.0% | 1.6% | |||
Avg | 6.4% | -1.3% | -5.7% | |||
Low | 0.1% | -11.1% | -13.9% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 1.13 | 7.89 | 7.55 | |||
Avg | 0.92 | 7.12 | 6.47 | |||
Low | 0.80 | 6.46 | 5.04 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | -70.6% | 755.6% | 6.1% | |||
Avg | -76.1% | 672.1% | -9.1% | |||
Low | -79.2% | 600.7% | -29.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.